Andrzej Wojnar

Polish pathologist oncologist

Born 1946-05-04 in Kraków (Q31487)

Andrzej Wojnar is …
instance of (P31):
humanQ5

External links are
P2671Google Knowledge Graph ID/g/11bzsnd9wr
P213ISNI000000011104287X
P12541Ludzie Nauki ID (new)MueuOIwACNx
P1207NUKAT IDn99044758
P7293PLWABN ID9810562746805606
P3124Polish scientist ID256508
P214VIAF ID161260959

P512academic degreehabilitationQ308678
P734family nameWojnarQ8029234
WojnarQ8029234
WojnarQ8029234
P735given nameAndrzejQ14941830
AndrzejQ14941830
P106occupationpathologistQ3368718
oncologistQ16062369
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q52337617Aberrant Expression of PIWIL1 and PIWIL2 and Their Clinical Significance in Ductal Breast Carcinoma.
Q36250185Angiotensin II type 1 receptor (AT-1R) expression correlates with VEGF-A and VEGF-D expression in invasive ductal breast cancer
Q79374099Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial
Q83890377CD24 expression is specific for tamoxifen-resistant ductal breast cancer cases
Q85162394Cavernous haemangioma of the oviduct
Q42950387Correlation between metallothionein (MT) expression and selected prognostic factors in ductal breast cancers.
Q92048637Correlation of Expression of CHI3L1 and Nogo-A and their Role in Angiogenesis in Invasive Ductal Breast Carcinoma
Q38413617Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers
Q84830895Correlation of intensity of MT-I/II expression with Ki-67 and MCM-2 proteins in invasive ductal breast carcinoma
Q46439112Differences in oestrogen and progesterone receptors, HER-2, p53 expression and proliferation in ductal breast cancers in relation to histopathological grade
Q46023402Differentiated expression of estrogen receptors (ER) and progesterone receptors (PgR) in ductal breast cancers.
Q86300318Discrepancies between HER2 assessment from core needle biopsies and surgical specimens of invasive ductal breast carcinoma
Q46394391Distal bowel surgical margin shorter than 1 cm after preoperative radiation for rectal cancer: is it safe?
Q46985667Distal intramural spread of rectal cancer after preoperative radiotherapy: the results of a multicenter randomized clinical study
Q47895470Evaluation of apoptosis, proliferation intensity and metallothionein (MT) expression in comparison with selected clinicopathological variables in primary adenocarcinomas of the large intestine.
Q38393018Expression of SATB1 protein in the ductal breast carcinoma tissue microarrays - preliminary study
Q39208543Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma
Q38731339Expression of metallothionein 3 in ductal breast cancer
Q89219396Expression of p16 and SATB1 in Invasive Ductal Breast Cancer - A Preliminary Study
Q47810017Expression of periostin in breast cancer cells.
Q38398888Hsp-27 expression in invasive ductal breast carcinoma
Q54242111Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma.
Q95527487Impact of different tumour stroma assessment methods regarding podoplanin expression on clinical outcome in patients with invasive ductal breast carcinoma
Q83229747Infralevator lymphatic drainage of low-rectal cancers: preliminary results
Q80385410Lack of relationship between metallothionein (MT) expression and proliferation exponents in cells of primary ductal breast cancer of G2 grade of differentiation
Q52933305Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates.
Q54292996Matrix metalloproteinase (MMP)-2 and MMP-9 expression in tumor infiltrating CD3 lymphocytes from women with endometrial cancer.
Q54333727Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma.
Q40676851Prognostic Significance of NOGO-A/B and NOGO-B Receptor Expression in Malignant Melanoma - A Preliminary Study
Q44368912Prognostic value of immunocytochemical determination of parathyroid hormone-related peptide expression in cells of mammary ductal carcinoma. Analysis of 7 years of the disease course.
Q24813854Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance
Q45201964Steroid receptor status, proliferation and metallothionein expression in primary invasive ductal breast cancers
Q79805609Stromal myofibroblasts in breast cancer: relations between their occurrence, tumor grade and expression of some tumour markers
Q58605865Sulfatide decreases the resistance to stress-induced apoptosis and increases P-selectin-mediated adhesion: a two-edged sword in breast cancer progression
Q88923599The Role of CHI3L1 Expression in Angiogenesis in Invasive Ductal Breast Carcinoma
Q79343622The expression of selected immunocytochemical diagnostic markers in the case of chondrosarcoma with a mesenchymal component
Q53130268Therapeutic radiation induces different changes in expression profiles of metallothionein (MT) mRNA, MT protein, Ki 67 and minichromosome maintenance protein 3 in human rectal adenocarcinoma.
Q38404863Tissue microarray technique in evaluation of proliferative activity in invasive ductal breast cancer
Q84132829Tumour regression grading in patients with residual rectal cancer after preoperative chemoradiation
Q81674092[The relationship of the expression of proliferetron--related antigens Ki67 and PCNA in the cells of ductal breast cancer with the differentiation grade]

The articles in Wikimedia projects and languages

      Andrzej Wojnarwikipedia

Search more.